Pacific Biosciences of California Reports Bigger Loss in Q4

Three months ago Pacific Biosciences of California NASDAQ PACB surpassed expectations with its third quarter results That good news wasn t enough to keep shares from continuing to fall though The genetic sequencing company announced its fourth quarter results after the